References
- Juliano J, Wilson KD, Gertner E. Vasculitis of the gallbladder: case report and spectrum of disease. J Clin Rheumatol. 2009;15(2):75–7.
- Ichinose K, Iwanaga N, Okada A, Tamai M, Yamasaki S, Nakamura H, et al. A case of microscopic polyangiitis in an elderly patient presenting predominantly with cholecystitis successfully treated with mizoribine. Mod Rheumatol. 2014;24(6):1011–4.
- Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore). 2005;84(2):323–30.
- Onishi S, Hojo N, Sakai I, Yasukawa M, Hato T, Minamoto Y, et al. Rupture of the gallbladder in a patient with acquired factor VIII inhibitors and systemic lupus erythematosus. Intern Med. 2004;43(11):1073–7.
- Jha NK, Kumar RA, Ayman M, Khan JA, Cristaldi M, Ahene C, et al. Ischemic gall bladder perforation: a complication of type A aortic dissection. Ann Thorac Surg. 2013;95(6):e155–6.
- Chin MW, Enns R. Hemobilia. Curr Gastroenterol Rep. 2010;12(2):121–9.
- Blouhos K, Boulas KA, Tselios DG, Hatzigeorgiadis A. Spontaneous hemocholecyst in an end-stage renal failure patient on low molecular weight heparin hemodialysis. Case Rep Surg. 2012;2012(2012):363924.
- Borman N, Graetz K. Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin. NDT Plus. 2010;3(4):376–8
- Zangrandi F, Piotto A, Tregnaghi A, Pelizzo MR. Hemocholecyst associated with antithrombotic therapy. Can J Surg. 2009;52(6): E297–8.
- Hagiuda J, Kawachi S, Kameyama K, Kitajima M. A case of gallbladder bleeding probably caused by angitis due to systemic lupus erythematosus (in Japanese with English abstract). J Jpn Surg Assoc. 2004;65:2185–9.
- Taniguchi M, Kanai S, Kitamura M, Nakamura I, Nakamura T, Shimomatsuya T. A case of gallbladder hemorrhage with intraperitoneal bleeding (in Japanese with English abstract). J Jpn Surg Assoc. 2013;74(2):503–7.
- Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004;19(6):1403–11.
- de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, et al. Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol. 2006;17(8):2264–74.
- Lionaki S, Hogan SL, Jennette CE, Hu Y, Hamra JB, Jennette JC, et al. The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int. 2009;76(6):644–51.
- Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41(4):776–84.
- Ntatsaki E, Carruthers D, Chakravarty K, D’Cruz D, Harper L, Jayne D, et al. BSR and BHPR guideline for the management of adults with ANCA associated vasculitis. Rheumatology. 2014;53(12):2306–9.
- Altieri P, Sau G, Cao R, Barracca A, Menneas A, Micchittu B, et al. Immunosuppressive treatment in dialysis patients. Nephrol Dial Transplant. 2002;17(Suppl 8):2–9.
- Tomasson G, Grayson PC, Mahr AD, Lavalley M, Merkel PA. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis–a meta-analysis. Rheumatology (Oxford). 2012;51(1):100–9.
- Weidemann S, Andrassy K, Ritz E. ANCA in haemodialysis patients. Nephrol Dial Transplant. 1993;8(9):839–45.
- Chen YX, Zhang W, Chen XN, Ni LY, Shen PY, Wang WM, et al. Clinical analysis of ANCA-associated renal vasculitis patients with chronic dialysis. Clin Exp Rheumatol. 2014;32(3 suppl 82):S5–10.
- Romeu M, Couchoud C, Delarozière JC, Burtey S, Chiche L, Harlé JR, et al. Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011. QJM. 2014;107(7):545–55.
- Walsh M, Flossmann O, Berden A, Westman K, Höglund P, Stegeman C, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64(2):542–8.